EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Enhancing Japanese encephalitis diagnosis with differential ELISA testing in India: A comparative evaluation of two JE IgM capture ELISA kits

Nayana Siddalingaiah, Vijayalakshmi Reddy, Dhanya K, Surbhi Telang, Lonika Lodha, Priya Kumari, M A Ashwini, Reeta S Mani

Journal of Vector Borne Diseases · 2026-07 · 63 (3) · 419-423

DOI: 10.4103/jvbd.jvbd_43_25 ↗
AbstractBibliografische Angaben

Abstract

Background & objectives: Japanese encephalitis (JE) remains a significant public health concern in India. IgM capture ELISA is widely used for laboratory confirmation, but cross-reactivity with other flaviviruses like dengue virus (DENV) can lead to false positives in endemic countries like India. To overcome this problem, World Health Organization recommends an IgM capture ELISA-based differential testing algorithm which includes JE IgM testing followed by DEN IgM testing. This study evaluates the performance of JE and DEN IgM capture ELISA kits from National Institute of Virology (NIV), Pune, India in differentiating JEV and DENV infections using ELISA-based differential testing algorithm in comparison with Inbios JE and DEN detect IgM capture ELISA kits. Methods: A total of 131 serum samples from patients with suspected AES were tested initially using both NIV JE IgM ELISA kit and Inbios JE detect followed by NIV DEN IgM and Inbios DEN detect kits, and results were compared. Results: The NIV kit showed a higher JE IgM positivity rate (77.9%) than the Inbios kit (69.5%). Differential testing reclassified 21.5% (22/102) of NIV JE IgM positive cases and 16.4% (15/91) of Inbios JE IgM positive cases as DEN positive. Interpretation & conclusion: The results emphasise the presence of cross reactivity between the JEV and DENV viruses. Despite limitations such as the absence of plaque reduction neutralization tests (PRNT), the findings support differential testing as a cost-effective strategy to enhance JE diagnostic accuracy in resource limited settings and reinforce the need for improved diagnostic algorithms to prevent misclassification of flavivirus infections especially in endemic countries.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →